COMMUNIQUÉS West-GlobeNewswire

Press release: CMS Approves Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases
05/08/2025
CMS Approves Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases alfapump® New Technology Add-on Payment (NTAP) Included in CMS Final Fiscal Year 2026 Rule and in effect by October 1, [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 31 - 2025
05/08/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 28 juillet au 01 août 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2025
05/08/2025
Aggregated presentation by day and by market Statement of transactions in own shares from July 28th to August 1 st 2025 Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 juillet 2025
05/08/2025
VALNEVA Déclaration d’actions et de droits de vote 31 juillet 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]
VALNEVA Declaration of shares and voting rights: July 31, 2025
05/08/2025
VALNEVA Declaration of shares and voting rights July 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
Corbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
05/08/2025
Phase 1/2 dose expansion data for Nectin-4 targeting ADC CRB-701 to be presented at ESMO 2025 Initiated 7-day MAD portion of Phase 1 study for obesity drug CRB-913 All three clinical programs (CRB-701, CRB-913, CRB-601 [...]
electroCore Appoints James C. Theofilos to the Board of Directors
05/08/2025
ROCKAWAY, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that James C. Theofilos has been appointed to the Board [...]
Opus Genetics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
05/08/2025
RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc . (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases ( [...]
ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025
05/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies [...]
CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference
05/08/2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company management will [...]
Vireo Growth Inc. to Release Second Quarter 2025 Results on August 13, 2025
05/08/2025
MINNEAPOLIS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its second fiscal quarter ended June [...]
Izotropic’s IzoView Positioned to Capitalize on Key Global Breast Imaging Market Drivers
05/08/2025
- Global breast imaging market projected to reach $8.69 billion by 2030, with IzoView addressing key clinical and commercial trends driving demand - Company positioned to lead in dense breast imaging, where rising [...]
IMUNON Reports Second Quarter 2025 Financial Results and Provides Business Update
05/08/2025
Stock dividend issued to IMUNON shareholders reflects confidence in clinical programs, long-term growth strategy and dedication to rewarding shareholders First patient dosed in Phase 3 OVATION 3 Study of IMNN-001 for [...]
InspireMD Reports Second Quarter 2025 Financial Results
05/08/2025
--- Management to host investor conference call today, August 5 th , at 8:30am ET --- MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard ® Prime carotid stent system for the [...]
Tecan schedules conference call on August 12th to discuss half year 2025 financial results
05/08/2025
Männedorf, Switzerland, August 5, 2025 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2025 on Tuesday, August 12th, 2025 at 08:30 [...]
Mesa Labs Announces First Quarter Results
05/08/2025
LAKEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced [...]
HOOPP launches 2030 Strategic Plan to build a stronger financial future for Ontario’s healthcare community
05/08/2025
Five-year plan seeks to drive member value and portfolio resilience TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) is proud to announce the launch of its 2030 Strategic Plan, a [...]
CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production
05/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) [...]
Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 Phase 1 Clinical Study of NPM-115
05/08/2025
LIBERATE-1, the first-in-human application of Vivani’s NanoPortal TM implant technology, showed a positive safety and tolerability profile, along with encouraging performance data for NPM-115 that met the study’s [...]

Pages